Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006397
Abstract: Key Points Early changes in ctDNA dynamics are prognostic in untreated MCL. Bortezomib maintenance after bortezomib-based induction therapy does not improve outcome in untreated MCL. read more here.
Keywords: circulating tumor; outcome; predicts therapeutic; dna predicts ... See more keywords